Breaking Down GBS Inc. (GBS) Financial Health: Key Insights for Investors

US | Healthcare | Medical - Devices | NASDAQ

GBS Inc. (GBS) Bundle

Get Full Bundle:
$9 $7
$9 $7
$9 $7
$9 $7
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Investors weighing GBS Inc.'s outlook will want to parse a mix of sturdy operational signals and sharp headwinds: total revenue for fiscal 2025 came in at $12.87 billion, a 5.8% decline year‑over‑year, with the Global Business Services segment at $6.65 billion (-2.6%) and Global Infrastructure Services at $6.23 billion (-9.1%), even as both GBS and GIS improved book‑to‑bill to 1.03x; profitability swung higher with EBIT of $696 million (a 260.6% increase) and adjusted EBIT margin at 7.9%, while diluted EPS rose to $2.10 (+356.5%) and non‑GAAP EPS to $3.43 (+10.6%), yet balance sheet contrasts are stark - the company reports no long‑term debt and cash of $5.74 million against current assets of $8.21 million and retained earnings of -$32.38 million, even as operating cash flow for fiscal 2025 was $0 and management projects FY2026 revenue between $12.18 billion and $12.44 billion amid an expected organic decline of 5.0% to 3.0% - read on to uncover how these figures map to valuation signals, liquidity risks, and the growth levers that could reshape GBS's trajectory.

GBS Inc. (GBS) - Revenue Analysis

GBS Inc. reported total revenue of $12.87 billion for fiscal year 2025, a 5.8% decrease versus the prior year. Revenue performance was split across two primary segments-Global Business Services (GBS) and Global Infrastructure Services (GIS)-each showing differing rates of decline and improving book-to-bill dynamics.
  • Total revenue (FY2025): $12.87 billion (‑5.8% YoY)
  • GBS segment revenue: $6.65 billion (‑2.6% YoY)
  • GIS segment revenue: $6.23 billion (‑9.1% YoY)
  • GBS book-to-bill: 1.03x (up from 0.96x in FY2024)
  • GIS book-to-bill: 1.03x (up from 0.86x in FY2024)
  • FY2026 organic revenue outlook: decline of 5.0% to 3.0%; projected total revenue $12.18B-$12.44B
Metric FY2025 YoY Change FY2024 (for context)
Total Revenue $12.87B ‑5.8% $13.65B (implied)
GBS Segment Revenue $6.65B ‑2.6% $6.83B (implied)
GIS Segment Revenue $6.23B ‑9.1% $6.86B (implied)
GBS Book-to-Bill 1.03x ↑ from 0.96x 0.96x
GIS Book-to-Bill 1.03x ↑ from 0.86x 0.86x
FY2026 Revenue Guidance $12.18B-$12.44B Organic decline 5.0%-3.0% -
  • Improved book-to-bill ratios (both segments at 1.03x) point to stronger near-term backlog conversion despite revenue declines in FY2025.
  • GIS saw the sharper revenue contraction (‑9.1%), suggesting greater exposure to cyclical or discretionary infrastructure spend pressures.
  • GBS's milder decline (‑2.6%) plus book-to-bill improvement signals steadier demand for business services and potential stabilization.
  • Guidance for FY2026 implies continued top-line pressure: management expects organic revenue to fall 3.0%-5.0%, yielding $12.18B-$12.44B in total revenue.
For broader investor context and shareholder activity related to these revenue trends, see: Exploring GBS Inc. (GBS) Investor Profile: Who's Buying and Why?

GBS Inc. (GBS) - Profitability Metrics

GBS Inc. (GBS) delivered material improvements in core profitability in fiscal year 2025, driven by higher operating results and favorable non-GAAP adjustments. Key headline metrics show both strong absolute growth and margin expansion on an adjusted basis, while segment-level dynamics reflect mixed performance.
  • EBIT surged to $696 million in FY2025, a 260.6% increase versus FY2024.
  • Adjusted EBIT margin reached 7.9% in FY2025, up 1.0 percentage point year-over-year.
  • GBS segment profit margin: 12.0% in FY2025 (down from 12.6% in FY2024).
  • GIS segment profit margin: 7.2% in FY2025 (up from 7.0% in FY2024).
  • Diluted EPS: $2.10 in FY2025, a 356.5% increase year-over-year.
  • Non-GAAP diluted EPS: $3.43 in FY2025, up 10.6% year-over-year.
Metric FY2025 FY2024 Change
EBIT $696 million ≈$192.5 million +260.6%
Adjusted EBIT Margin 7.9% 6.9% +1.0 ppt
GBS Segment Profit Margin 12.0% 12.6% -0.6 ppt
GIS Segment Profit Margin 7.2% 7.0% +0.2 ppt
Diluted EPS $2.10 ≈$0.46 +356.5%
Non-GAAP Diluted EPS $3.43 $3.10 +10.6%
  • Primary drivers of the EBIT and EPS acceleration included improved operating leverage and one-time items reflected in adjusted results; the adjusted EBIT margin expansion of 1.0 ppt indicates stronger core profitability after adjustments.
  • Segment divergence: the GBS segment experienced a modest margin contraction (‑0.6 ppt), suggesting cost or mix pressure in that business, while GIS posted a small margin gain (+0.2 ppt), signaling incremental operational improvement.
  • The gap between GAAP diluted EPS ($2.10) and non-GAAP diluted EPS ($3.43) highlights non-GAAP adjustments that meaningfully increase reported per-share profitability.
For additional investor context and ownership dynamics, see: Exploring GBS Inc. (GBS) Investor Profile: Who's Buying and Why?

GBS Inc. (GBS) - Debt vs. Equity Structure

GBS Inc. (GBS) presents a capital structure characterized by negligible debt exposure and an equity base that reflects historical operating losses. The balance sheet as of fiscal year 2025 highlights a clean long-term debt profile and a liquidity position driven primarily by cash and current assets.
  • No long-term debt reported in fiscal year 2025, indicating absence of leverage on the long-duration side.
  • Total current liabilities: $2.36 million, with no deferred long-term liabilities recorded.
  • Shareholder equity: $5.28 million, while retained earnings are negative at -$32.38 million - signaling accumulated losses.
  • No goodwill or long-term investments on the balance sheet, simplifying asset composition.
  • Common stock recorded at $148,899 and a cash balance of $5.74 million, supporting near-term obligations and operations.
Balance Sheet Item Amount (USD)
Total current assets $8.21 million
Cash balance $5.74 million
Total current liabilities $2.36 million
Long-term debt $0
Deferred long-term liabilities $0
Long-term investments $0
Goodwill $0
Common stock $148,899
Retained earnings -$32.38 million
Shareholder equity $5.28 million
The lack of long-term debt reduces insolvency and interest-rate risk but the substantial negative retained earnings indicate prior operating deficits that have eroded cumulative profits. Liquidity appears adequate in the near term given current assets of $8.21 million versus current liabilities of $2.36 million, with cash representing the largest single asset. For context on ownership trends and investor activity related to these financial dynamics, see: Exploring GBS Inc. (GBS) Investor Profile: Who's Buying and Why?

GBS Inc. (GBS) - Liquidity and Solvency

Key liquidity and solvency metrics for fiscal year 2025 provide a snapshot of GBS Inc.'s ability to meet short-term obligations and fund operations without external debt.

  • Operating cash flow (FY2025): $0 - no cash generated from core operations during the year.
  • Capital expenditures (FY2025): $474,891.
  • Cash & short-term investments: $5,740,000.
  • Short-term debt: $0; Long-term debt: $0 - debt-free capital structure.
  • Current ratio: ~3.48.
  • Quick ratio (excl. inventory): ~3.48 - indicates strong immediate liquidity.
Metric Value
Operating cash flow (FY2025) $0
Capital expenditures (CapEx) $474,891
Cash & short-term investments $5,740,000
Short-term debt $0
Long-term debt $0
Current ratio (current assets / current liabilities) 3.48
Quick ratio (excl. inventory) 3.48
  • Strong cash reserves and zero debt reduce solvency risk but the $0 operating cash flow signals dependence on non-operating inflows or financing to cover CapEx and working capital.
  • High current and quick ratios indicate ample short-term coverage, but sustainability depends on restoring positive operating cash generation.

Further context on corporate priorities and long-term strategy: Mission Statement, Vision, & Core Values (2026) of GBS Inc.

GBS Inc. (GBS) - Valuation Analysis

Current market snapshot and valuation metrics for GBS Inc. (GBS) based on the latest available data:

  • Last traded price: $1.19 per share
  • 52-week range: $0.17 - $1.44
  • 50-day moving average: $0.35
  • 200-day moving average: $0.55
  • Short ratio: 1.84
  • Short percent of float: 0%
  • Insider ownership: 905.1%
  • Institutional ownership: 278.8%
  • Analyst target price: not specified
Metric Value
Last Price $1.19
52-Week High $1.44
52-Week Low $0.17
50-Day MA $0.35
200-Day MA $0.55
Short Ratio 1.84
Short % of Outstanding 0%
Insider Ownership 905.1%
Institutional Ownership 278.8%
Analyst Target Not specified

Key interpretative notes and context:

  • Price relative to moving averages: the last price ($1.19) sits well above both the 50-day ($0.35) and 200-day ($0.55) moving averages, indicating recent upward momentum versus medium- and long-term trends.
  • Volatility range: the 52-week spread ($0.17-$1.44) reflects substantial intra-year volatility; current price is closer to the upper end of that range.
  • Short interest dynamics: a short ratio of 1.84 suggests limited days-to-cover at current trading volumes; short percent outstanding reported as 0% signals negligible short exposure in the available dataset.
  • Ownership data anomalies: insider (905.1%) and institutional (278.8%) ownership figures exceed 100% and likely indicate data irregularities or reporting artifacts that should be validated with primary filings.
  • Analyst coverage: absence of a specified analyst target implies limited or no consensus analyst coverage at this time.

Further background on the company can be found here: GBS Inc. (GBS): History, Ownership, Mission, How It Works & Makes Money

GBS Inc. (GBS) Risk Factors

GBS Inc. (GBS) faces several material risks that investors should weigh carefully. Recent operational results and balance sheet metrics highlight pressures on revenue, profitability and liquidity that could constrain growth and increase financing needs.
  • Projected organic revenue decline of 5.0% to 3.0% in fiscal year 2026, indicating reduced top-line momentum.
  • GBS segment revenue fell 2.6% year-over-year, signaling potential demand weakness or competitive pressure in core operations.
  • GIS segment revenue declined 9.1% year-over-year, raising concerns about market share loss or execution challenges in that business line.
  • Net loss of $2,550,674 for the quarter ended March 31, 2025, reflecting ongoing profitability shortfalls.
  • Operating cash flow of $0 for fiscal year 2025, an acute liquidity indicator that limits flexibility to cover obligations or invest.
  • Negative retained earnings balance of -$32.38 million, which can restrict dividend capacity and indicate accumulated deficits.
Metric Amount / Change Period
Projected Organic Revenue Change -5.0% to -3.0% FY2026 (projection)
GBS Segment Revenue Change -2.6% YoY Most recent fiscal year
GIS Segment Revenue Change -9.1% YoY Most recent fiscal year
Net Income (Loss) -$2,550,674 Quarter ended Mar 31, 2025
Operating Cash Flow $0 FY2025
Retained Earnings -$32,380,000 As reported
Key areas where these figures translate into investor risk:
  • Liquidity risk - zero operating cash flow in FY2025 increases dependence on external financing or asset sales to fund operations and working capital.
  • Profitability risk - repeated quarterly losses (e.g., -$2.55M) amplify retained deficit and hinder balance sheet repair.
  • Revenue concentration and segment risk - double-digit declines in GIS and declines in GBS segment suggest vulnerability to sector cycles or loss of major customers.
  • Valuation and equity dilution risk - with negative retained earnings and cash flow shortfalls, future equity raises or debt issuances could dilute shareholders or increase leverage.
  • Execution risk - meeting FY2026 revenue projections requires operational improvements; failure could accelerate financial stress.
For additional context on shareholder composition and investor interest, see: Exploring GBS Inc. (GBS) Investor Profile: Who's Buying and Why?

GBS Inc. (GBS) - Growth Opportunities

GBS Inc. (GBS) shows early signs of expanding demand across both its services and infrastructure businesses, supported by targeted technology investments and recent product launches.
  • Book-to-bill trends indicate momentum: overall 1.03x, up from prior periods, signalling revenue intake slightly exceeding billings.
  • GBS segment book-to-bill improved to 1.03x from 0.96x, reflecting raised demand for service contracts and recurring engagements.
  • GIS segment book-to-bill rose to 1.03x from 0.86x, pointing to a pick-up in infrastructure services and project bookings.
Metric Most Recent Prior Period Notes
Consolidated book-to-bill 1.03x - Indicates bookings slightly exceed billings
GBS segment book-to-bill 1.03x 0.96x Higher services demand
GIS segment book-to-bill 1.03x 0.86x Infrastructure project growth
Planned technology expenditures (next fiscal year) $5,000,000+ - CapEx and IT adoption
Digital transformation investment (2023) $4,000,000 2023 Rollout of digital tools across functions
New products launched 3 2022 Product innovation driving pipeline
  • Planned >$5M technology spend next fiscal year to accelerate automation, cloud migration, and analytics-expected to improve gross margins over time by reducing manual costs and enabling higher-value offerings.
  • $4M invested in 2023 digital transformation to deploy CRM, ERP integration, and customer-facing portals-supports faster sales cycles and improved retention.
  • Three product launches in 2022 expand addressable market and cross-sell opportunities into existing accounts.
Key commercial levers to monitor:
  • Conversion of higher book-to-bill into recognized revenue and free cash flow.
  • ROI on technology investments measured by margin expansion, sales productivity, and time-to-deploy metrics.
  • Uptake of new products and their contribution to recurring revenue.
Further context on corporate strategy and background can be found here: GBS Inc. (GBS): History, Ownership, Mission, How It Works & Makes Money

DCF model

GBS Inc. (GBS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.